Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 35
2003 24
2004 17
2005 23
2006 16
2007 19
2008 16
2009 15
2010 17
2011 18
2012 19
2013 27
2014 27
2015 26
2016 27
2017 27
2018 18
2019 16
2020 33
2021 23
2022 16
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

427 results

Results by year

Filters applied: . Clear all
Page 1
Impact of tumor shrinkage pattern with biweekly triplet gemcitabine+cisplatin+S-1 regimen for biliary tract cancers: Implications for neoadjuvant therapy from the data of KHBO1401 (KHBO1401-1A study).
Kobayashi S, Wada H, Sakai D, Baba H, Kanai M, Kamachi H, Takayama T, Ueno M, Takahashi M, Sho M, Yoshimura K, Hatano E, Nagano H, Ioka T. Kobayashi S, et al. Among authors: takayama t. Oncology. 2023 Dec 4. doi: 10.1159/000533669. Online ahead of print. Oncology. 2023. PMID: 38048759
Comparison between CT volumetry, technetium99m galactosyl-serum-albumin scintigraphy, and gadoxetic-acid-enhanced MRI to estimate the liver fibrosis stage in preoperative patients.
Nakazawa Y, Okada M, Hyodo T, Tago K, Shibutani K, Mizuno M, Yoshikawa H, Abe H, Higaki T, Okamura Y, Takayama T. Nakazawa Y, et al. Among authors: takayama t. Eur Radiol. 2024 Apr;34(4):2212-2222. doi: 10.1007/s00330-023-10219-9. Epub 2023 Sep 7. Eur Radiol. 2024. PMID: 37673964
Clinical outcomes of second‑line chemotherapy after gemcitabine and cisplatin plus S‑1 treatment for patients with advanced biliary tract cancer in the KHBO1401‑3A study.
Shindo Y, Nagano H, Kanai M, Kobayashi S, Wada H, Sakai D, Eguchi H, Baba H, Kamachi H, Takayama T, Ueno M, Takahashi M, Nakagami Y, Yoshimura K, Hatano E, Ioka T. Shindo Y, et al. Among authors: takayama t. Oncol Rep. 2023 Feb;49(2):41. doi: 10.3892/or.2023.8478. Epub 2023 Jan 12. Oncol Rep. 2023. PMID: 36633148 Free PMC article.
427 results